These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7684516)
1. Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions. Doyle LW; Kelly EA; Rickards AL; Ford GW; Callanan C Obstet Gynecol; 1993 Jun; 81(6):931-5. PubMed ID: 7684516 [TBL] [Abstract][Full Text] [Related]
2. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Lindenburg IT; Smits-Wintjens VE; van Klink JM; Verduin E; van Kamp IL; Walther FJ; Schonewille H; Doxiadis II; Kanhai HH; van Lith JM; van Zwet EW; Oepkes D; Brand A; Lopriore E; Am J Obstet Gynecol; 2012 Feb; 206(2):141.e1-8. PubMed ID: 22030316 [TBL] [Abstract][Full Text] [Related]
3. Outcome at 2 years of children 23-27 weeks' gestation born in Victoria in 1991-92. The Victorian Infant Collaborative Study Group. J Paediatr Child Health; 1997 Apr; 33(2):161-5. PubMed ID: 9145362 [TBL] [Abstract][Full Text] [Related]
4. Outcome to five years of age of children born at 24-26 weeks' gestational age in Victoria. The Victorian Infant Collaborative Study Group. Doyle LW Med J Aust; 1995 Jul; 163(1):11-4. PubMed ID: 7541889 [TBL] [Abstract][Full Text] [Related]
5. Changing outcome over 13 years of very low birthweight infants. Kitchen WH; Ryan MM; Rickards A; Astbury J; Ford G; Lissenden JV; Keith CG; Keir EH Semin Perinatol; 1982 Oct; 6(4):373-89. PubMed ID: 7156995 [TBL] [Abstract][Full Text] [Related]
6. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997. Mikkola K; Ritari N; Tommiska V; Salokorpi T; Lehtonen L; Tammela O; Pääkkönen L; Olsen P; Korkman M; Fellman V Pediatrics; 2005 Dec; 116(6):1391-400. PubMed ID: 16322163 [TBL] [Abstract][Full Text] [Related]
7. Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome. De Jong EP; Lindenburg IT; van Klink JM; Oepkes D; van Kamp IL; Walther FJ; Lopriore E Am J Obstet Gynecol; 2012 Mar; 206(3):204.e1-5. PubMed ID: 22381602 [TBL] [Abstract][Full Text] [Related]
8. [Extreme prematurity: comparison of outcome at 5 years depending on gestational age below or above 26 weeks]. Autret F; Kieffer F; Tasseau A; Rigourd V; Valleur D; Voyer M; Magny JF Arch Pediatr; 2009 Jul; 16(7):976-83. PubMed ID: 19403280 [TBL] [Abstract][Full Text] [Related]
9. Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years. Grab D; Paulus WE; Bommer A; Buck G; Terinde R Obstet Gynecol; 1999 Feb; 93(2):165-8. PubMed ID: 9932548 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Nagel HT; de Haan TR; Vandenbussche FP; Oepkes D; Walther FJ Obstet Gynecol; 2007 Jan; 109(1):42-7. PubMed ID: 17197586 [TBL] [Abstract][Full Text] [Related]
11. Parents' evaluation of developmental status in children born with a birthweight of 1250 g or less. Pritchard MA; Colditz PB; Beller EM; J Paediatr Child Health; 2005 Apr; 41(4):191-6. PubMed ID: 15813873 [TBL] [Abstract][Full Text] [Related]
13. Improved outcome into the 1990s for infants weighing 500-999 g at birth. The Victorian Infant Collaborative Study Group. The V Arch Dis Child Fetal Neonatal Ed; 1997 Sep; 77(2):F91-4. PubMed ID: 9377152 [TBL] [Abstract][Full Text] [Related]
14. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Van Kamp IL; Klumper FJ; Oepkes D; Meerman RH; Scherjon SA; Vandenbussche FP; Kanhai HH Am J Obstet Gynecol; 2005 Jan; 192(1):171-7. PubMed ID: 15672021 [TBL] [Abstract][Full Text] [Related]
15. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. Janssens HM; de Haan MJ; van Kamp IL; Brand R; Kanhai HH; Veen S J Pediatr; 1997 Sep; 131(3):373-80. PubMed ID: 9329412 [TBL] [Abstract][Full Text] [Related]
16. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age. O'Shea TM; Washburn LK; Nixon PA; Goldstein DJ Pediatrics; 2007 Sep; 120(3):594-602. PubMed ID: 17766533 [TBL] [Abstract][Full Text] [Related]
17. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD; Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228 [TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental outcome at 2 years in 23 to 26 weeks old gestation infants. Sommer C; Urlesberger B; Maurer-Fellbaum U; Kutschera J; Müller W Klin Padiatr; 2007; 219(1):23-9. PubMed ID: 16586271 [TBL] [Abstract][Full Text] [Related]
19. Epidemiological study of cerebral palsy in the Maribor region. Burja S; Seme-Ciglenecki P; Gajsek-Marchetti M; Hajdinjak D; Levanic A; Kodelic B Wien Klin Wochenschr; 2004; 116 Suppl 2():39-43. PubMed ID: 15506309 [TBL] [Abstract][Full Text] [Related]
20. Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Schendel D; Bhasin TK Pediatrics; 2008 Jun; 121(6):1155-64. PubMed ID: 18519485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]